This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2026
Title: Lucas Altepost and Patent Innovation in Pulmonary Fibrosis Treatment.
Introduction
Lucas Altepost is an inventor associated with Nesøya, Norway, and Axichem AB. His patent work concerns potential approaches to treating idiopathic pulmonary fibrosis, a serious lung disease.
Latest Patents
Altepost is associated with 1 patent: “Capsaicin Derivatives in the Treatment of Idiopathic Pulmonary Fibrosis.” The invention describes compounds and compositions for use in treating idiopathic pulmonary fibrosis. It also addresses methods for inhibiting the activity of platelet-derived growth factor receptors PDGF-α and/or PDGF-β in a subject in need of treatment.
Career Highlights
The available information connects Altepost’s inventive work with Axichem AB and research into therapeutic applications of capsaicin derivatives. His patent focuses on a specific disease-treatment area and related biological targets.
Collaborations
Altepost’s listed coworkers include Erik Lager and Torsten Helsing. Their names provide context for the professional network associated with his work.
Conclusion
Lucas Altepost’s patent activity centers on a proposed therapeutic approach to idiopathic pulmonary fibrosis, including compounds and methods involving PDGF receptor inhibition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile